18F FDG uptake in the large arteries: A correlation study with the atherogenic risk factors

https://doi.org/10.1053/snuc.2002.29279Get rights and content

It has been reported that there is a high correlation between fluorodeoxyglucose (FDG) uptake in the aorta and macrophage content of atherosclerotic lesions in an experimental rabbit model. We evaluated the frequency of FDG uptake in the large arteries in relation to the atherogenic risk factors. We also investigated whether FDG uptake of the large arteries is related to clinically known coronary artery disease. The presence of FDG uptake was assessed in the abdominal aorta (AA), iliac (IA), and proximal femoral arteries (FAs) in 156 patients. Medical history of the atherogenic risk factors (age, cigarette smoking, hypertension, diabetes, high cholesterol, and obesity) and coronary artery disease (CAD) was identified for each patient. The frequency of vascular FDG uptake was compared between the patients without risk factors (Group 1, 23 patients) and those with at least 1 risk factor (Group II, 133 patients). The correlation of each risk factor and known CAD with arterial FDG uptake was also assessed in the 3 different arteries. There was a significant difference in the frequency of FDG uptake between the 2 groups for the FA (22% vs 70%) and IA (30% vs 54%), but not for the AA (35% vs 53%). Among all risk factors, age was the most significant and consistent factor correlating with FDG uptake in all 3 arteries. Hypercholesterolemia also correlated consistently with FDG uptake in all 3 arteries. The correlation between the remaining risk factors and arterial FDG uptake was rather artery specific than consistent throughout all 3 arteries. A higher frequency of FDG uptake in the FA was seen in patients with CAD compared with those without CAD. Not all risk factors correlated with FDG uptake in different arteries. Among the risk factors, age and hypercholesterolemia most consistently correlated with FDG uptake in the AA, and the IA and proximal FAs. The positive correlation of arterial FDG uptake with the atherogenic risk factors suggested a promising role for FDG-PET imaging in the diagnosis of atherosclerosis and follow-up after treatment intervention.

References (55)

  • StaryH et al.

    A definition of the intima of human arteries and of its atherosclerosis-prone regions. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

    Circulation

    (1992)
  • BiermanE

    Disorders of the vascular system

  • YamadaS et al.

    High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue

    J Nucl Med

    (1995)
  • VallabhajosulaS et al.

    Imaging atherosclerotic macrophage density by positron emission tomography using F-18-fluorodeoxyglucose

    J Nucl Med

    (1996)
  • MachacJ et al.

    18 F fluorodeoxyglucose uptake in human thoracic aortas assessed in vivo by positron emission tomography

    J Nucl Med

    (2001)
  • RossR

    Atherosclerosis — an inflammatory disease

    N Engl J Med

    (1999)
  • WilsonP et al.

    Prediction of coronary heart disease using risk factor categories

    Circulation

    (1998)
  • KarpJ et al.

    Singles transmission in volume-imaging PET with a 137Cs source

    Phys Med Biol

    (1995)
  • BedigianM et al.

    Whole-body positron emission tomography for oncology imaging using singles transmission scanning with segmentation and ordered subsets-expectation maximization (OS-EM) reconstruction

    Eur J Nucl Med

    (1998)
  • ShreveP et al.

    Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants

    Radiographics

    (1999)
  • StumpeK et al.

    Infection imaging using whole-body FDG-PET

    Eur J Nucl Med

    (2000)
  • HaraM et al.

    FDG-PET finding in early-phase Takayasu arteritis

    J Comput Assist Tomogr

    (1999)
  • BlockmansD et al.

    New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography

    Rheumatology

    (1999)
  • PetermansJ

    Prevalence of disease of the large arteries in an elderly Belgian population: Relationship with some metabolic factors

    Acta Cardiol

    (1984)
  • StaryH et al.

    A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association

    Circulation

    (1995)
  • BilatoC et al.

    Atherosclerosis and the vascular biology of aging

    Aging (Milano)

    (1996)
  • BraunwaldE

    Shattuck lecture—cardiovascular medicine at the turn of the millennium: Triumphs, concerns, and opportunities

    N Engl J Med

    (1997)
  • Cited by (187)

    • Clinical imaging techniques for assessing vascular risk and complications in the lower extremities

      2021, Diabetes and Cardiovascular Disease: Volume 3 in Computer-Assisted Diagnosis
    • PET Scan with Fludeoxyglucose/Computed Tomography in Low-Grade Vascular Inflammation

      2020, PET Clinics
      Citation Excerpt :

      Vascular FDG uptake in subclinical atherosclerosis, a chronic low-grade inflammatory disease, has long been documented through PET imaging in major vessels throughout the body, usually the aorta, carotids, and most recently the coronary arteries.11 FDG PET uptake was first incidentally noted in the vascular wall of large arteries, during an oncologic-indicated examination, and found that FDG vascular uptake correlated with CV risk factors.12 Validation of FDG PET as a marker of the inflammation in an atherosclerotic plaque originated from in vitro histology studies, including immunostaining for macrophages in endarterectomy samples from carotid plaques.13,14

    View all citing articles on Scopus
    View full text